logo-loader
G Medical Innovations Holdings Ltd

G Medical Innovations appoints expert in health management systems as non-executive director

Professor Zeev Rotstein is an internationally recognised cardiologist and expert in health management systems.

Professor Zeev Rotstein
G Medical is moving ahead towards dual listing on the NASDAQ

G Medical Innovations Holdings Ltd (ASX:GMV) has appointed Professor Zeev Rotstein to the position of non-executive director.

Professor Rotstein is an internationally recognised cardiologist and expert in health management systems, with decades of experience across consultancy and academia.

He is currently serving as the director general, Hadassah Medical Organization; associate clinical professor, The Hebrew University of Jerusalem; and associate clinical professor, Sackler School of Medicine Tel Aviv University.

READ: G Medical Innovations delivers revenue growth; secures first US commercial order

Professor Rostein has acted as an expert consultant in the construction of several medical facilities throughout the world including Centro Medico La Paz, Equatorial Guinea, the Lagoon Hospital, Accra, Ghana and currently the Moscow Medical Cluster Oncological Centre and Polyclinic of Skolkovo, Moscow.

He is trained in medicine at Tel Aviv University, and has held fellowships at the New York Department of Health, Tufts University, and Johns Hopkins Medical Centre School of Hygiene and Public Health.

Professor Rostein joins G Medical as the company farewell Louis Antoniou, president - business development, who has resigned for family reasons.

READ: G Medical Innovations moving towards US public offering and NASDAQ listing

G Medical president and chief executive officer Dr. Yacov Geva said: “We welcome Professor Rotstein to the G Medical Board.

“He brings a wealth of international experience to the company as we accelerate our process towards our dual listing on the NASDAQ.

“We would also like to again thank Louis for his tireless work for the company. He has been an integral team member since the ASX IPO.”

Quick facts: G Medical Innovations Holdings Ltd

Price: $0.13

Market: ASX
Market Cap: $49.76 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of G Medical Innovations Holdings Ltd named herein, including the promotion by the Company of G Medical Innovations Holdings Ltd in any Content on...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Australian e-health company G Medical Innovations eyes Nasdaq listing

G Medical Innovations Holdings Ltd (ASX:GMV) CEO Yacov Geva sits down with Proactive Investors' Christine Corrado in New York to update investors on the mobile and e-health company's move to list on the Nasdaq. Geva says the company, which specializes in software and devices that aim to...

on 10/15/2018

2 min read